C. Hill

发表

The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase.

R. Wolfert, C. Hill, 1990, Clinica chimica acta; international journal of clinical chemistry.

Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay.

D. Baylink, J. Farley, B. Miller, 1994, Clinical chemistry.

Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity.

Denise, P. Henthorn, M. Whyte, 1996, The Journal of clinical endocrinology and metabolism.

Immunoassay of human calcitonin.

A. Tashjian, K. Melvin, C. Hill, 1970, The New England journal of medicine.

Direct nucleic acid diagnostic tests for bacterial infectious diseases: streptococcal pharyngitis, pulmonary tuberculosis, vaginitis, chlamydial and gonococcal infections.

F. Paillard, C. Hill, 2004, MLO: medical laboratory observer.

Molecular diagnostic testing for infectious diseases using TMA technology

C. Hill, Craig S Hill, 2001, Expert review of molecular diagnostics.

Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity.

P. Henthorn, M. Whyte, C. Hill, 1996, The Journal of clinical endocrinology and metabolism.

Bone Alkaline Phosphatase in Paget's Disease

R. Wolfert, L. Deftos, C. Hill, 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.

C. Giachetti, Astrid R. W. Schroder, J. Dockter, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prevalence of Trichomonas vaginalis and Coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as Determined by the Aptima Trichomonas vaginalis Nucleic Acid Amplification Assay

K. Chapin, C. Ginocchio, C. Gaydos, 2012, Journal of Clinical Microbiology.

Ease and Comfort of Cervical and Vaginal Sampling for Chlamydia trachomatis and Trichomonas vaginalis with a New Aptima Specimen Collection and Transportation Kit

L. Elit, M. Smieja, A. Lytwyn, 2013, Journal of Clinical Microbiology.

Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.

E. Portillo, C. Pritchard, M. Smieja, 2009, Sexually transmitted diseases.

High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya

C. Poole, J. Kimani, V. Schoenbach, 2013, Sexually transmitted diseases.

Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing

J. Schwebke, C. Hill, A. Merriweather, 2017, Sexually transmitted diseases.

Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

M. Patnaik, T. Yashina, C. Hill, 2004, Journal of Clinical Microbiology.

Two-site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule.

R. Wolfert, L. Deftos, D. Burton, 1992, Clinical chemistry.

Evaluation of a New APTIMA Specimen Collection and Transportation Kit for High-Risk Human Papillomavirus E6/E7 Messenger RNA in Cervical and Vaginal Samples

L. Elit, J. Dockter, M. Smieja, 2014, Sexually transmitted diseases.

High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya

C. Poole, J. Kimani, V. Schoenbach, 2013, Sexually transmitted diseases.